Jushi Holdings Inc. Reports Unaudited, Preliminary Fourth Quarter and Full Year 2022 Financial Results

3 years ago

Q4 2022 Revenue Increased 16.6% YoY to $76.8 million and FY 2022 Revenue Increased 35.8% to a Record $284.3 million…

Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus

3 years ago

– IND application cleared within 6 months of in-licensing CABA-201 binder – – CABA-201 data package and experience from prior…

InvestmentPitch Media Video Discusses Reliq Health and its Signing of 10 Contracts Potentially Adding 5,000 new Patients to its iUGO Platform by Year End

3 years ago

VANCOUVER, British Columbia, March 31, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global…

Eledon Reports Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation at World Congress of Nephrology

3 years ago

Results from three participants demonstrated no incidence of acute rejection at durations of 56, 154, and 232 days Strong graft…

Nexstim Plc: Resolutions of the Annual General Meeting of Shareholders

3 years ago

Company Announcement, Helsinki, 31 March 2023 at 1 PM (EEST) Nexstim Plc: Resolutions of the Annual General Meeting of Shareholders…

Junshi Biosciences Announces 2022 Full Year Financial Results and Provides Corporate Updates

3 years ago

SHANGHAI, China, March 31, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a…

Mendus AB: Change in number of shares and votes in Mendus AB (publ)

3 years ago

During March, the number of shares and votes in Mendus AB (publ) has changed as a result of 1,137,790 new…

Study shows significant improvement in bladder emptying with Coloplast’s Luja™ compared to competitor catheter

3 years ago

Luja Coloplast's intermittent male catheter LujaStudy results show that Coloplast’s new intermittent male catheter with 80+ micro-holes, Luja, achieved complete…

Valneva Announces Filing of 2022 Universal Registration Document and US Form 20-F

3 years ago

Saint-Herblain (France), March 31, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the…

Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD

3 years ago

Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD Pixium Vision to receive interactive communication…